Pharma

Your Article Summary

See Latest Articles

TRIN Pharma appoints new CEO
b3c newswire, 11/10/09

TRIN Pharma GmbH, specializing in the development of small molecule drugs for tumor treatment, has announced that effective October 2009, Dr. Stefan Wohlfeil has been appointed new CEO of TRIN Pharma. Stefan Wohlfeil previously held the position of Chief Medical Officer at TRIN Pharma. The change in management takes place at a time, where TRIN Pharma is moving its lead molecule TRIN 2755 into Phase I clinical development.

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09

Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09

 See all of Research & Development